More than 15 million people in the U.S. are affected by COPD (chronic obstructive pulmonary disease), a condition that damages the lungs and makes it hard to breathe. 1 But a diagnosis doesn’t have to ...
Recently, the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application for Trelegy Ellipta for the maintenance treatment of asthma in patients ages 18 years and older.
Medicare Part D prescription drug plans may cover Trelegy Ellipta inhalers. Out-of-pocket costs can vary by plan and insurer, but you may only have to pay a 25% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback